Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIK Cells for Advanced Hepatocellular Carcinoma
NCT02568748Phase 3Unknown
- Start
- Oct 2015
- Primary completion
- Jun 2019
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 3 trial of unmodified CIK in hepatocellular carcinoma (HCC). Status: unknown.
02
Drugs
unmodified CIK
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02568748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02568748.